0.1304
price down icon3.12%   -0.0042
after-market Dopo l'orario di chiusura: .13 -0.0004 -0.31%
loading

Bioatla Inc Borsa (BCAB) Ultime notizie

pulisher
Apr 02, 2026

BioAtla Announces 1-for-50 Reverse Stock Split Merger - TipRanks

Apr 02, 2026
pulisher
Apr 02, 2026

[8-K] BioAtla, Inc. Reports Material Event - Stock Titan

Apr 02, 2026
pulisher
Apr 02, 2026

BCAB Stock Price, Quote & Chart | BIOATLA INC (NASDAQ:BCAB) - ChartMill

Apr 02, 2026
pulisher
Apr 02, 2026

12 Health Care Stocks Moving In Wednesday's Intraday Session - Sahm

Apr 02, 2026
pulisher
Apr 01, 2026

BioAtla To Carry Out 1-for-50 Reverse Stock Split On April 6th, 2026 - Moomoo

Apr 01, 2026
pulisher
Mar 31, 2026

BioAtla Begins Strategic Review Following 2025 Results - TipRanks

Mar 31, 2026
pulisher
Mar 31, 2026

BioAtla Announces 50-for-1 Share Consolidation - National Today

Mar 31, 2026
pulisher
Mar 31, 2026

BioAtla Announces Share Consolidation - Investing News Network

Mar 31, 2026
pulisher
Mar 31, 2026

12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga

Mar 31, 2026
pulisher
Mar 31, 2026

BioAtla announces 50-for-1 reverse stock split effective April 6 - Investing.com

Mar 31, 2026
pulisher
Mar 31, 2026

BioAtla to implement 50-for-1 share consolidation - MSN

Mar 31, 2026
pulisher
Mar 31, 2026

BioAtla Q4 net loss narrows on lower expenses - TradingView

Mar 31, 2026
pulisher
Mar 31, 2026

BioAtla Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights - marketscreener.com

Mar 31, 2026
pulisher
Mar 31, 2026

BioAtla shrinks share count 50-for-1 to meet Nasdaq's $1 bid rule - Stock Titan

Mar 31, 2026
pulisher
Mar 31, 2026

BRIEF-BioAtla Q4 Net Income USD -9.784 Million - TradingView

Mar 31, 2026
pulisher
Mar 31, 2026

Strategic shake-up at BioAtla (NASDAQ: BCAB) as oncology pipeline and funding plans are reassessed - Stock Titan

Mar 31, 2026
pulisher
Mar 31, 2026

BioAtla (NASDAQ: BCAB) posts 2025 loss, launches asset monetization review - Stock Titan

Mar 31, 2026
pulisher
Mar 31, 2026

With $7.1M cash, BioAtla weighs asset sales and slower trial pacing - Stock Titan

Mar 31, 2026
pulisher
Mar 30, 2026

Aug Decliners: How much upside does BioAtla Inc haveCPI Data & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn

Mar 30, 2026
pulisher
Mar 27, 2026

Aug Wrap: Will BioAtla Inc stock hit new highs in YEAR2026 Bull vs Bear & AI Based Trade Execution Alerts - baoquankhu1.vn

Mar 27, 2026
pulisher
Mar 26, 2026

Signal Recap: How much upside does BioAtla Inc have2026 Sector Review & Stepwise Swing Trade Plans - baoquankhu1.vn

Mar 26, 2026
pulisher
Mar 25, 2026

Buyout Rumor: Can BioAtla Inc deliver consistent dividends2026 Decliners & Risk Managed Investment Signals - baoquankhu1.vn

Mar 25, 2026
pulisher
Mar 24, 2026

BioAtla Shareholders Approve Merger and Share Consolidation - theglobeandmail.com

Mar 24, 2026
pulisher
Mar 24, 2026

BioAtla, Inc. 8-K SEC Filing March 17, 2026: Company Information, Key Details, and Legal Disclosures - minichart.com.sg

Mar 24, 2026
pulisher
Mar 23, 2026

BioAtla (NASDAQ: BCAB) approves merger, 1-for-50 reverse split and 2026 executive retention bonuses - Stock Titan

Mar 23, 2026
pulisher
Mar 20, 2026

842,440 shares issued to YA II PN, Ltd.; BioAtla (NASDAQ: BCAB) registers resale - Stock Titan

Mar 20, 2026
pulisher
Mar 18, 2026

Breakout Watch: What is the dividend yield of BioAtla IncEarnings Growth Summary & Technical Buy Zone Confirmation - baoquankhu1.vn

Mar 18, 2026
pulisher
Mar 17, 2026

BCAB Technical Analysis | Trend, Signals & Chart Patterns | BIOATLA INC (NASDAQ:BCAB) - ChartMill

Mar 17, 2026
pulisher
Mar 13, 2026

BioAtla (NASDAQ: BCAB) to issue 631,163 shares to Yorkville under SEPA - Stock Titan

Mar 13, 2026
pulisher
Mar 12, 2026

BioAtla (NASDAQ: BCAB) CMO receives 240,000-share time-based RSU award - Stock Titan

Mar 12, 2026
pulisher
Mar 12, 2026

BioAtla (NASDAQ: BCAB) CEO receives 430,000-share RSU grant - Stock Titan

Mar 12, 2026
pulisher
Mar 12, 2026

BioAtla (BCAB) CFO awarded 240,000 restricted stock units, total holdings 530,196 shares - Stock Titan

Mar 12, 2026
pulisher
Mar 10, 2026

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Mar 10, 2026
pulisher
Mar 07, 2026

Published on: 2026-03-07 14:29:43 - Naître et grandir

Mar 07, 2026
pulisher
Mar 03, 2026

BioAtla launches major restructuring and leadership transition - The Globe and Mail

Mar 03, 2026
pulisher
Mar 02, 2026

BioAtla explores sale as it cuts 70% of workforce - Investing.com South Africa

Mar 02, 2026
pulisher
Mar 02, 2026

BioAtla (BCAB) CFO sees 1,802 shares withheld for RSU tax settlement - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

[Form 4] BioAtla, Inc. Insider Trading Activity - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

BioAtla (BCAB) CMO reports 3,140-share tax withholding on RSU vesting - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

BioAtla explores sale as it cuts 70% of workforce By Investing.com - Investing.com India

Mar 02, 2026
pulisher
Mar 02, 2026

BioAtla, Inc. Initiates Strategic Review Process and Workforce Restructuring to Enhance Shareholder Value - Quiver Quantitative

Mar 02, 2026
pulisher
Mar 02, 2026

BioAtla Inc announces 70% workforce reductionSEC filing - marketscreener.com

Mar 02, 2026
pulisher
Mar 02, 2026

BioAtla appoints Chris Vasquez as CFO as Richard Waldron departs - TradingView

Mar 02, 2026
pulisher
Mar 02, 2026

BioAtla (NASDAQ: BCAB) slashes workforce 70% amid strategic review, listing risk - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

BioAtla, Inc. Implements Workforce Reduction of Approximately 70% - marketscreener.com

Mar 02, 2026
pulisher
Mar 02, 2026

Bioatla announces formal process to evaluate strategic options to monetize assets - marketscreener.com

Mar 02, 2026
pulisher
Mar 02, 2026

Bioatla Announces Formal Process To Evaluate Strategic Options To Monetize Assets - TradingView

Mar 02, 2026
pulisher
Mar 02, 2026

Biotech BioAtla to shed 70% of staff while weighing asset sales - Stock Titan

Mar 02, 2026
pulisher
Mar 01, 2026

BCAB PE Ratio & Valuation, Is BCAB Overvalued - Intellectia AI

Mar 01, 2026
pulisher
Mar 01, 2026

US Market Wrap: Does BioAtla Inc meet Warren Buffetts criteria2025 Retail Activity & Low Drawdown Momentum Ideas - baoquankhu1.vn

Mar 01, 2026
pulisher
Mar 01, 2026

Aug Sentiment: Is BioAtla Inc forming bullish engulfing patterns2025 Geopolitical Influence & Long-Term Safe Return Strategies - baoquankhu1.vn

Mar 01, 2026
pulisher
Mar 01, 2026

BioAtla, Inc. (NASDAQ:BCAB) Sees Large Drop in Short Interest - Defense World

Mar 01, 2026
pulisher
Feb 28, 2026

BioAtla (BCAB) CEO has shares withheld to cover RSU taxes - Stock Titan

Feb 28, 2026
pulisher
Feb 27, 2026

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Feb 27, 2026
pulisher
Feb 25, 2026

BioAtla to Participate in the Citizens Life Sciences Conference - 富途牛牛

Feb 25, 2026
pulisher
Feb 25, 2026

Gap Down: Will BioAtla Inc stock hit new highs in YEAR2025 Bull vs Bear & Accurate Intraday Trading Signals - baoquankhu1.vn

Feb 25, 2026
pulisher
Feb 22, 2026

BCABBioatla, Inc. Latest Stock News & Market Updates - Stock Titan

Feb 22, 2026
pulisher
Feb 19, 2026

12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga

Feb 19, 2026
$99.12
price up icon 0.49%
$28.33
price up icon 1.76%
$48.57
price up icon 0.16%
$91.18
price up icon 1.97%
ONC ONC
$310.79
price up icon 0.76%
$162.43
price down icon 1.47%
Capitalizzazione:     |  Volume (24 ore):